Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical ALK5 Inhibitor, Vactosertib, Reverses TGFβ-1 Stimulated Smad-2 Driven Ineffective Hematopoiesis in MDS

Srinivas Aluri, Kimo Bachiashvili, MD, Anjali Budhathoki, MD, Tushar D Bhagat, PhD, Gaurav S Choudhary, PhD, Shanisha Gordon, Nandini Ramachandra, Kith Pradhan, PhD, Shahina Maqbool, Aditi Shastri, MD, Jung Im Huh, Sunjin Hwang, Kim Seong-Jin, PhD, Hui Zhang, Britta Will, PhD, Amittha Wickrema, PhD, Ulrich G. Steidl, MD PhD, Amit Verma, MBBS

Blood (2019) 134 (Supplement_1): 2990.

https://doi.org/10.1182/blood-2019-127561

Published: 2019

Journal Articles

Autologous Transplantation Is Associated with Better Outcomes Compared to Chemotherapy Alone in a Minority-Rich Non-High-Risk Acute Myeloid Leukemia Cohort

Diego Adrianzen Herrera, MD, Nilupa Gaspe Mudiyanselage, MD, Pramod Gaudel, MD, Anjali Budhathoki, MD, Karine Darbinyan, MD, Aditi Shastri, MD, Murali Janakiram, MD, Adam F. Binder, MD, Noah Kornblum, MD, Olga Derman, Kira Gritsman, MD PhD, Ulrich G. Steidl, MDPhD, Amit Verma, MD, Ira Braunschweig, MD, Ioannis Mantzaris, MD

Blood (2017) 130 (Supplement 1): 3293.

https://doi.org/10.1182/blood.V130.Suppl_1.3293.3293

Published: 2017

Journal Articles

What Is the Patient Risk from a Bone Marrow Biopsy By Hematologists-in-Training? A Prospective, Clinical Study

Shirin Attarian, MD, Louis Juden Reed, MD, Shashi Singh, MD, Gopichand Pendurti, MBBS, Alexander Shestopalov, MD, Aditi P. Singh, MD, Anjali Budhathoki, MD, Simon Abi Aad, MD, Urvi A Shah, MD, Salem Kim, MD, Kimo Bachiashvili, MD, Tarek Elrafei, DO, Karenza Alexis, MD, Marianna Strakhan, MD, Weijuan Li, MS,MD, Conway Yee, MD, Ellen W. Friedman, MD

Blood (2017) 130 (Supplement 1): 5638.

https://doi.org/10.1182/blood.V130.Suppl_1.5638.5638

Published: 2017

Journal Articles

Anisocytosis Predicts Worse Survival in Secondary Polycythemia

Jose Nahun Galeas, MD, Nilupa Gaspe, MD, Kith Pradhan, PhD, Hernando Cordero, MD, Anjali Budhathoki, MD, Amit Verma, MD, Swati Goel, MD

Blood (2016) 128 (22): 1254.

https://doi.org/10.1182/blood.V128.22.1254.1254

Published: 2016

Journal Articles

Hispanic Ethnicity Is Associated with Younger Age at Presentation and Worse Survival in AML

Karine Antonovna Darbinyan, MD, Daniel Helbig, MDcal Student, Junaid Saleh Esa, College student, Anjali Budhathoki, MD, Swati Goel, MD, Aditi Shastri, MD, Murali Janakiram, MD, Noah Kornblum, MD, Olga Derman, MD, Kira Gritsman, MD PhD, Ulrich Steidl, MD PhD, Amit Verma, MD, Ira Braunschweig, MD, Ioannis Mantzaris, MD

Blood (2016) 128 (22): 3600.

https://doi.org/10.1182/blood.V128.22.3600.3600

Published: 2016

NARROW

Clinical ALK5 Inhibitor, Vactosertib, Reverses TGFβ-1 Stimulated Smad-2 Driven Ineffective Hematopoiesis in MDS

Autologous Transplantation Is Associated with Better Outcomes Compared to Chemotherapy Alone in a Minority-Rich Non-High-Risk Acute Myeloid Leukemia Cohort

What Is the Patient Risk from a Bone Marrow Biopsy By Hematologists-in-Training? A Prospective, Clinical Study

Anisocytosis Predicts Worse Survival in Secondary Polycythemia

Hispanic Ethnicity Is Associated with Younger Age at Presentation and Worse Survival in AML

Email alerts

ASH Publications

American Society of Hematology

Clinical ALK5 Inhibitor, Vactosertib, Reverses TGFβ-1 Stimulated Smad-2 Driven Ineffective Hematopoiesis in MDS

Autologous Transplantation Is Associated with Better Outcomes Compared to Chemotherapy Alone in a Minority-Rich Non-High-Risk Acute Myeloid Leukemia Cohort

What Is the Patient Risk from a Bone Marrow Biopsy By Hematologists-in-Training? A Prospective, Clinical Study

Anisocytosis Predicts Worse Survival in Secondary Polycythemia

Hispanic Ethnicity Is Associated with Younger Age at Presentation and Worse Survival in AML

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only